Log in to the corporate email account
Chinese|English|Spanish
Website Home
About Dier
Product Solution
Clinical Microbiology Testing Solutions
Bacterial/Fungal Morphological Examination Protocol
Fully automated blood culture system
Bacterial Identification and Antimicrobial Susceptibility Testing System
Fully Automated Biomass Spectrometry Detection System
Urogenital Infection Diagnostic Products
Industrial Microbial Testing Solutions
Bacterial identification system
In-Hospital Infection Control Solutions
Hospital Infection Management System
Infectious Disease Management System
Immunoassay and Molecular Diagnostic Solutions
Microbial Dynamic Detection System
User Services
News Updates
Contact Dier
MALDI‑TOF MS Search
Technical Exchange
Dier Information
Dier Bio Supports the Rational Use of Antimicrobial Agents | 2021 World Antimicrobial Awareness Week
21
2023
/
06
Interpretation of the Chinese Expert Consensus on the Prevention of Perinatal Group B Streptococcal Disease
Strengthening in-hospital infection prevention and control in maternal and child health institutions—Group B Streptococcus must not be overlooked!
Strengthen the development of the “two networks” and enhance the rational use of medications in medical institutions.
Standardizing the Use of Antimicrobial Agents to Support the Development of Domestic Medical Devices—2021 Industry Policy Analysis
Dier Biotech helps you effectively address the issue of quinolone interference in Enterobacteriaceae detection results.